Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
This study investigated serotonin transporter (SERT) complexes with ibogaine to illustrate structure-based mechanisms for transport in serotonin transporter (SERT). The investigation reported that cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, closed and inward-open conformations with ibogaine binding to the central binding site, and the closing extracellular gate with movements of TMs 1b and 6a. The intracellular gate opening had a hinge-like movement of TM1a and the partial unwinding of TM5 that together built a permeation pathway enabling substrate and ion diffusion to the cytoplasm. These structures show the structural rearrangements which occur from the outward-open to inward-open conformations, and give an important insight into the working mechanism of neurotransmitter transport and ibogaine inhibition.
Authors
- Coleman, J. A.
- Yang, D.
- Zhao, Z.
Published
Abstract
The serotonin transporter (SERT) regulates neurotransmitter homeostasis through the sodium- and chloride-dependent recycling of serotonin into presynaptic neurons. Major depression and anxiety disorders are treated using selective serotonin reuptake inhibitors-small molecules that competitively block substrate binding and thereby prolong neurotransmitter action. The dopamine and noradrenaline transporters, together with SERT, are members of the neurotransmitter sodium symporter (NSS) family. The transport activities of NSSs can be inhibited or modulated by cocaine and amphetamines, and genetic variants of NSSs are associated with several neuropsychiatric disorders including attention deficit hyperactivity disorder, autism and bipolar disorder. Studies of bacterial NSS homologues-including LeuT-have shown how their transmembrane helices (TMs) undergo conformational changes during the transport cycle, exposing a central binding site to either side of the membrane. However, the conformational changes associated with transport in NSSs remain unknown. To elucidate structure-based mechanisms for transport in SERT we investigated its complexes with ibogaine, a hallucinogenic natural product with psychoactive and anti-addictive properties. Notably, ibogaine is a non-competitive inhibitor of transport but displays competitive binding towards selective serotonin reuptake inhibitors. Here we report cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conformations. Ibogaine binds to the central binding site, and closure of the extracellular gate largely involves movements of TMs 1b and 6a. Opening of the intracellular gate involves a hinge-like movement of TM1a and the partial unwinding of TM5, which together create a permeation pathway that enables substrate and ion diffusion to the cytoplasm. These structures define the structural rearrangements that occur from the outward-open to inward-open conformations, and provide insight into the mechanism of neurotransmitter transport and ibogaine inhibition.
Research Summary of 'Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport'
Introduction
The serotonin transporter (SERT) is a sodium- and chloride-dependent membrane protein that terminates serotonergic signalling by recapturing serotonin into presynaptic neurons. SERT belongs to the neurotransmitter sodium symporter (NSS) family alongside the dopamine and noradrenaline transporters; these transporters are targets for antidepressant drugs (selective serotonin reuptake inhibitors) and are modulated by psychostimulants such as cocaine and amphetamines. Although structural studies of bacterial NSS homologues (for example LeuT) have outlined large-scale transmembrane helix movements during the transport cycle, the conformational changes that underlie transport and inhibition in eukaryotic SERT remained incompletely characterised. Coleman and colleagues set out to define structure-based mechanisms of transport and inhibition in human SERT by determining cryo-electron microscopy (cryo-EM) structures of SERT bound to ibogaine, a psychoactive alkaloid reported to be a non-competitive inhibitor of SERT. The study aimed to capture SERT in multiple transport-related conformations, locate the ibogaine-binding site, characterise ligand interactions, and combine structural data with biochemical, mutational and computational approaches (docking and molecular dynamics) to explain how ibogaine inhibits transport and how SERT transitions between outward-open, occluded and inward-open states.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- APA Citation
Coleman, J. A., Yang, D., Zhao, Z., Wen, P., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. (2019). Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport. Nature, 569(7754), 141-145. https://doi.org/10.1038/s41586-019-1135-1
Cited By (5)
Papers in Blossom that reference this study
Geoly, A. D., Coetzee, J. P., Buchanan, D. M. et al. · iScience (2026)
Ona, G., Reverte, I., Rossi, G. N. et al. · Journal of Psychopharmacology (2023)
Mash, D. C. · Pharmacological Research (2023)
González, J., Cavelli, M., Castro-Zaballa, S. et al. · ACS Pharmacology and Translational Science (2021)
Rodríguez, P., Urbanavicius, J., Prieto, J. P. et al. · ACS Chemical Neuroscience (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.